68 related articles for article (PubMed ID: 3446273)
1. Glycaemic control and exercise tolerance in hypertensive insulin-treated diabetes during nifedipine therapy.
Winocour PH; Waldek S; Cohen H; Anderson DC; Gordon C
Br J Clin Pract; 1987 Jun; 41(6):772-8. PubMed ID: 3446273
[No Abstract] [Full Text] [Related]
2. [Extracardiovascular effects of nifedipine in the treatment of hypertensive patients: glucose tolerance and behavior of immunoreactive insulin].
Vulpis V; Antonacci A; Pirrelli A
Cardiologia; 1988 Feb; 33(2):139-42. PubMed ID: 3282657
[No Abstract] [Full Text] [Related]
3. [Does long-term blood pressure reduction in patients with essential hypertension improve concomitant metabolic disorders?].
Hauner H; Meissner C
Med Klin (Munich); 1994 Aug; 89(8):403-9. PubMed ID: 7968872
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with nifedipine modulates procoagulant marker and C-C chemokine in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Shouzu A; Omoto S; Nishikawa M; Iwasaka T
Thromb Res; 2005; 115(4):277-85. PubMed ID: 15668187
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of atenolol versus nifedipine on serum lipids and other biochemical parameters in diabetic and non-diabetic hypertensive subjects.
Satia MC; Shukla ML; Goyal RK
Indian J Physiol Pharmacol; 1995 Jul; 39(3):237-41. PubMed ID: 8550116
[TBL] [Abstract][Full Text] [Related]
6. Effect of nicardipine in a hypertensive patient with diabetes mellitus.
Sakata S; Miura K
Clin Ther; 1984; 6(5):600-2. PubMed ID: 6478468
[TBL] [Abstract][Full Text] [Related]
7. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
[TBL] [Abstract][Full Text] [Related]
8. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus.
Nomura S; Inami N; Kimura Y; Omoto S; Shouzu A; Nishikawa M; Iwasaka T
J Hum Hypertens; 2007 Jan; 21(1):38-44. PubMed ID: 17051237
[TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment with nifedipine does not alter carbohydrate tolerance in normal subjects and does not worsen metabolic control in diabetics].
Gasparoni P; Caroli A; Berno R; Cecchetto G; Zanlungo P; Sardeo G; Carbone G; Volpi A
Clin Ter; 1987 Jan; 120(2):131-4. PubMed ID: 2972442
[No Abstract] [Full Text] [Related]
10. [Effect of postprandial exercise in type I diabetes: comparison between the continuous-infusion insulin pump and intensified conventional therapy].
Goicolea I; Rueda M; Hernández I; Quiroga A; Vázquez JA
Rev Clin Esp; 1986 Nov; 179(7):355-8. PubMed ID: 3541079
[No Abstract] [Full Text] [Related]
11. [Influence of nifedipine on the response to exercise in hypertensive patients].
Giusti C; Mosti G; Tomei G; Galetta F
Boll Soc Ital Cardiol; 1978; 23(10):1767-72. PubMed ID: 261839
[No Abstract] [Full Text] [Related]
12. Nifedipine in angina and blood glucose levels in diabetics.
Madhu S; Singh Verma NP; Singh B
J Assoc Physicians India; 1986 Nov; 34(11):773-6. PubMed ID: 3558298
[No Abstract] [Full Text] [Related]
13. [Latent arterial hypertension in type 1 diabetes. Ergometric evaluations in diabetics, non-diabetics and hypertensive non-diabetics].
Iannelli M; Avogliero G; Ainardi A; Marandino A; Mozzone A; Martino P; Vitelli A
Minerva Endocrinol; 1984; 9(2):269-73. PubMed ID: 6503912
[No Abstract] [Full Text] [Related]
14. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study.
Lind L; Berne C; Pollare T; Lithell H
J Hum Hypertens; 1995 Feb; 9(2):137-41. PubMed ID: 7752176
[TBL] [Abstract][Full Text] [Related]
15. [Essential hypertension. Treatment with nifedipine and levels of insulin, glucagon, gastrin and prolactin].
Wnuk R; Kokot F
Kardiol Pol; 1991; 34(6):351-4. PubMed ID: 1942746
[TBL] [Abstract][Full Text] [Related]
16. [Acute effects of nifedipine and verapamil on arterial pressure, at rest and during and after exercise in hypertensive patients].
Novo S; Riolo F; Pinto A; Davì G; Botindari C
Boll Soc Ital Cardiol; 1980; 25(2):157-63. PubMed ID: 7236440
[No Abstract] [Full Text] [Related]
17. [Glyco-lipid changes in hypertensive diabetic patients undergoing treatment with nifedipine and captopril].
Cicco G; Pirrelli A
Minerva Med; 1993 Mar; 84(3):119-24. PubMed ID: 8492963
[TBL] [Abstract][Full Text] [Related]
18. Metabolic predictors of hypertension.
Haffner SM
J Hypertens Suppl; 1999 Aug; 17(3):S23-8. PubMed ID: 10489095
[TBL] [Abstract][Full Text] [Related]
19. Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus.
Dominguez JR; de la Calle H; Hurtado A; Robles RG; Sancho-Rof J
Postgrad Med J; 1986; 62 Suppl 1():66-8. PubMed ID: 3534865
[TBL] [Abstract][Full Text] [Related]
20. [The assessment of glucose tolerance in hypertensive subjects treated with amlodipine].
Panuccio D; Romani A; Trabatti MR; Romanelli R; Nardi R
Clin Ter; 1993 Oct; 143(4):309-13. PubMed ID: 8258265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
